Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $765,628 - $1.09 Million
-29,504 Reduced 15.36%
162,616 $4.54 Million
Q4 2022

Feb 14, 2023

BUY
$24.79 - $30.86 $590,324 - $734,869
23,813 Added 14.15%
192,120 $5 Million
Q3 2022

Nov 14, 2022

SELL
$24.62 - $32.44 $16,126 - $21,248
-655 Reduced 0.39%
168,307 $4.37 Million
Q2 2022

Aug 15, 2022

SELL
$19.74 - $29.01 $520,662 - $765,167
-26,376 Reduced 13.5%
168,962 $4.62 Million
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $1.93 Million - $3.02 Million
72,503 Added 59.02%
195,338 $5.21 Million
Q4 2021

Feb 14, 2022

SELL
$33.67 - $43.44 $164,949 - $212,812
-4,899 Reduced 3.84%
122,835 $4.93 Million
Q3 2021

Nov 15, 2021

SELL
$30.65 - $35.68 $729,776 - $849,540
-23,810 Reduced 15.71%
127,734 $4.17 Million
Q2 2021

Aug 16, 2021

BUY
$34.33 - $44.68 $307,871 - $400,690
8,968 Added 6.29%
151,544 $5.23 Million
Q1 2021

May 17, 2021

SELL
$40.81 - $53.88 $1.34 Million - $1.77 Million
-32,853 Reduced 18.73%
142,576 $6.14 Million
Q4 2020

Feb 12, 2021

BUY
$36.63 - $47.63 $3.82 Million - $4.97 Million
104,298 Added 146.63%
175,429 $7.65 Million
Q3 2020

Nov 12, 2020

SELL
$30.09 - $43.02 $443,466 - $634,028
-14,738 Reduced 17.16%
71,131 $2.76 Million
Q2 2020

Aug 14, 2020

BUY
$27.76 - $33.42 $8,910 - $10,727
321 Added 0.38%
85,869 $2.78 Million
Q1 2020

May 12, 2020

BUY
$20.69 - $37.79 $1.77 Million - $3.23 Million
85,548 New
85,548 $2.56 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.09B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.